» Articles » PMID: 12239348

Megakaryocytes Derived from Embryonic Stem Cells Implicate CalDAG-GEFI in Integrin Signaling

Overview
Specialty Science
Date 2002 Sep 20
PMID 12239348
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Fibrinogen binding to integrin alphaIIbbeta3 mediates platelet aggregation and requires agonist-induced "inside-out" signals that increase alphaIIbbeta3 affinity. Agonist regulation of alphaIIbbeta3 also takes place in megakaryocytes, the bone marrow cells from which platelets are derived. To facilitate mechanistic studies of inside-out signaling, we describe here the generation of megakaryocytes in quantity from murine embryonic stem (ES) cells. Coculture of ES cells for 8-12 days with OP9 stromal cells in the presence of thrombopoietin, IL-6, and IL-11 resulted in the development of large, polyploid megakaryocytes that produced proplatelets. These cells expressed alphaIIbbeta3 and platelet glycoprotein Ibalpha but were devoid of hematopoietic stem cell, erythrocyte, and leukocyte markers. Mature megakaryocytes, but not megakaryocyte progenitors, specifically bound fibrinogen by way of alphaIIbbeta3 in response to platelet agonists. Retrovirus-mediated expression of the reporter gene, green fluorescent protein, in ES cell-derived megakaryocytes did not affect viability or alphaIIbbeta3 function. On the other hand, retroviral expression of CalDAG-GEFI, a Rap1 exchange factor identified by megakaryocyte gene profiling as a candidate integrin regulator, enhanced agonist-induced activation of Rap1b and fibrinogen binding to alphaIIbbeta3 (P < 0.01). These results establish that ES cells are a ready source of mature megakaryocytes for integrin studies and other biological applications, and they implicate CalDAG-GEFI in inside-out signaling to alphaIIbbeta3.

Citing Articles

The novel antitumor compound clinopodiside A induces cytotoxicity autophagy mediated by the signaling of BLK and RasGRP2 in T24 bladder cancer cells.

Zhou R, Zhao J, Guo L, Guo J, Makawy A, Li Z Front Pharmacol. 2022; 13:982860.

PMID: 36199691 PMC: 9527273. DOI: 10.3389/fphar.2022.982860.


The Connection Between Rap1 and Talin1 in the Activation of Integrins in Blood Cells.

Sun H, Lagarrigue F, Ginsberg M Front Cell Dev Biol. 2022; 10:908622.

PMID: 35721481 PMC: 9198492. DOI: 10.3389/fcell.2022.908622.


Erythroid Differentiation of Induced Pluripotent Stem Cells Co-cultured with OP9 Cells for Diagnostic Purposes.

Roh J, Kim S, Cheong J, Jeon S, Kim H, Kim M Ann Lab Med. 2022; 42(4):457-466.

PMID: 35177566 PMC: 8859560. DOI: 10.3343/alm.2022.42.4.457.


Integrins and their role in megakaryocyte development and function.

Yang X, Chitalia S, Matsuura S, Ravid K Exp Hematol. 2021; 106:31-39.

PMID: 34910941 PMC: 8795491. DOI: 10.1016/j.exphem.2021.11.007.


Multiple myeloma cells induce lipolysis in adipocytes and uptake fatty acids through fatty acid transporter proteins.

Panaroni C, Fulzele K, Mori T, Siu K, Onyewadume C, Maebius A Blood. 2021; 139(6):876-888.

PMID: 34662370 PMC: 8832479. DOI: 10.1182/blood.2021013832.


References
1.
Pampori N, Hato T, Stupack D, Aidoudi S, Cheresh D, Nemerow G . Mechanisms and consequences of affinity modulation of integrin alpha(V)beta(3) detected with a novel patch-engineered monovalent ligand. J Biol Chem. 1999; 274(31):21609-16. DOI: 10.1074/jbc.274.31.21609. View

2.
Rojnuckarin P, Kaushansky K . Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase calpha. Blood. 2001; 97(1):154-61. DOI: 10.1182/blood.v97.1.154. View

3.
Bennett J, Zigmond S, Vilaire G, Cunningham M, Bednar B . The platelet cytoskeleton regulates the affinity of the integrin alpha(IIb)beta(3) for fibrinogen. J Biol Chem. 1999; 274(36):25301-7. DOI: 10.1074/jbc.274.36.25301. View

4.
Calderwood D, Zent R, Grant R, Rees D, Hynes R, Ginsberg M . The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem. 1999; 274(40):28071-4. DOI: 10.1074/jbc.274.40.28071. View

5.
Fabre J, Nguyen M, LaTour A, Keifer J, Audoly L, Coffman T . Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Nat Med. 1999; 5(10):1199-202. DOI: 10.1038/13522. View